M.D.C. Holdings, Inc. (MDC) Expected to Post Earnings of $0.72 Per Share

Analysts forecast that M.D.C. Holdings, Inc. (NYSE:MDC) will post earnings per share of $0.72 for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for M.D.C.’s earnings, with estimates ranging from $0.68 to $0.76. M.D.C. reported earnings of $1.04 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 30.8%. The firm is expected to report its next earnings report on Wednesday, August 7th.

According to Zacks, analysts expect that M.D.C. will report full year earnings of $3.16 per share for the current financial year, with EPS estimates ranging from $2.84 to $3.50. For the next financial year, analysts forecast that the business will post earnings of $3.20 per share, with EPS estimates ranging from $2.93 to $3.65. Zacks’ earnings per share averages are an average based on a survey of sell-side research analysts that that provide coverage for M.D.C..

M.D.C. (NYSE:MDC) last issued its earnings results on Tuesday, April 30th. The construction company reported $0.64 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.59 by $0.05. M.D.C. had a net margin of 6.90% and a return on equity of 14.20%. The firm had revenue of $647.28 million for the quarter, compared to analysts’ expectations of $597.26 million. During the same quarter last year, the company posted $0.63 earnings per share. M.D.C.’s revenue was up 6.5% on a year-over-year basis.

A number of equities analysts have issued reports on the stock. Zacks Investment Research cut shares of M.D.C. from a “buy” rating to a “hold” rating in a report on Saturday, May 4th. Wedbush reissued a “neutral” rating and issued a $30.00 target price on shares of M.D.C. in a report on Wednesday, May 1st. Finally, ValuEngine cut shares of M.D.C. from a “hold” rating to a “sell” rating in a report on Tuesday, January 22nd. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $32.40.

Shares of NYSE MDC opened at $32.03 on Tuesday. The company has a current ratio of 8.58, a quick ratio of 2.19 and a debt-to-equity ratio of 0.68. M.D.C. has a 52-week low of $25.14 and a 52-week high of $33.47. The stock has a market capitalization of $1.96 billion, a price-to-earnings ratio of 8.73, a price-to-earnings-growth ratio of 1.42 and a beta of 1.33.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 29th. Stockholders of record on Wednesday, May 15th will be issued a dividend of $0.30 per share. The ex-dividend date is Tuesday, May 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 3.75%. M.D.C.’s dividend payout ratio (DPR) is presently 30.25%.

In other news, SVP Michael Touff sold 36,741 shares of M.D.C. stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $28.84, for a total transaction of $1,059,610.44. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, COO David D. Mandarich sold 55,000 shares of M.D.C. stock in a transaction that occurred on Monday, February 25th. The shares were sold at an average price of $29.65, for a total value of $1,630,750.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 308,187 shares of company stock worth $9,289,562. Corporate insiders own 26.30% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Penserra Capital Management LLC bought a new stake in shares of M.D.C. during the first quarter valued at approximately $56,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of M.D.C. by 25.8% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,326 shares of the construction company’s stock valued at $93,000 after buying an additional 683 shares during the last quarter. Bank of Montreal Can raised its holdings in shares of M.D.C. by 14.1% during the fourth quarter. Bank of Montreal Can now owns 4,908 shares of the construction company’s stock valued at $138,000 after buying an additional 605 shares during the last quarter. Quantamental Technologies LLC raised its holdings in shares of M.D.C. by 2,807.7% during the first quarter. Quantamental Technologies LLC now owns 5,641 shares of the construction company’s stock valued at $164,000 after buying an additional 5,447 shares during the last quarter. Finally, Meeder Asset Management Inc. bought a new stake in shares of M.D.C. during the fourth quarter valued at approximately $173,000. 83.50% of the stock is currently owned by institutional investors.

About M.D.C.

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

Featured Story: How do taxes affect a CDs total return?

Get a free copy of the Zacks research report on M.D.C. (MDC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.